A combined in silico and in vitro study on mouse Serpina1a antitrypsin-deficiency mutants.
Name:
Eggenschwiler et al.pdf
Size:
1.985Mb
Format:
PDF
Description:
Open Accesss publication
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Eggenschwiler, RetoPatronov, Atanas
Hegermann, Jan
Fráguas-Eggenschwiler, Mariane
Wu, Guangming
Cortnumme, Leon
Ochs, Matthias
Antes, Iris
Cantz, Tobias
Issue Date
2019-05-16
Metadata
Show full item recordAbstract
Certain point-mutations in the human SERPINA1-gene can cause severe α1-antitrypsin-deficiency (A1AT-D). Affected individuals can suffer from loss-of-function lung-disease and from gain-of-function liver-disease phenotypes. However, age of onset and severity of clinical appearance is heterogeneous amongst carriers, suggesting involvement of additional genetic and environmental factors. The generation of authentic A1AT-D mouse-models has been hampered by the complexity of the mouse Serpina1-gene locus and a model with concurrent lung and liver-disease is still missing. Here, we investigate point-mutations in the mouse Serpina1a antitrypsin-orthologue, which are homolog-equivalent to ones known to cause severe A1AT-D in human. We combine in silico and in vitro methods and we find that analyzed mutations do introduce potential disease-causing properties into Serpina1a. Finally, we show that introduction of the King’s-mutation causes inactivation of neutrophil elastase inhibitory-function in both, mouse and human antitrypsin, while the mouse Z-mutant retains activity. This work paves the path to generation of better A1AT-D mouse-models.Citation
Sci Rep. 2019 May 16;9(1):7486. doi: 10.1038/s41598-019-44043-3.Affiliation
TWINCORE, Zentrum für experimentelle und klinische Infektionsforschung GmbH,Feodor-Lynen Str. 7, 30625 Hannover, Germany.Publisher
Springer-NatureJournal
Scientific reportsPubMed ID
31097772Type
ArticleISSN
2045-2322ae974a485f413a2113503eed53cd6c53
10.1038/s41598-019-44043-3
Scopus Count
Collections
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-ShareAlike 4.0 International
Related articles
- Deletion of Serpina1a, a murine α1-antitrypsin ortholog, results in embryonic lethality.
- Authors: Wang D, Wang W, Dawkins P, Paterson T, Kalsheker N, Sallenave JM, Houghton AM
- Issue date: 2011 Jun
- Alpha-1 antitrypsin deficiency: a conformational disease associated with lung and liver manifestations.
- Authors: Greene CM, Miller SD, Carroll T, McLean C, O'Mahony M, Lawless MW, O'Neill SJ, Taggart CC, McElvaney NG
- Issue date: 2008 Feb
- Null(Canada): A novel α(1)-antitrypsin allele with in cis variants Glu366Lys and Ile100Asn.
- Authors: Chen S, DeMarco ML, Estey MP, Kyle B, Parker ML, Agbor TA, Kawada P, Speevak M, Nelson TN, Mattman A
- Issue date: 2020 May
- Characterization of Novel Missense Variants of SERPINA1 Gene Causing Alpha-1 Antitrypsin Deficiency.
- Authors: Matamala N, Lara B, Gomez-Mariano G, Martínez S, Retana D, Fernandez T, Silvestre RA, Belmonte I, Rodriguez-Frias F, Vilar M, Sáez R, Iturbe I, Castillo S, Molina-Molina M, Texido A, Tirado-Conde G, Lopez-Campos JL, Posada M, Blanco I, Janciauskiene S, Martinez-Delgado B
- Issue date: 2018 Jun
- Functional characterization of the mouse Serpina1 paralog DOM-7.
- Authors: Jülicher K, Wähner A, Haase K, Barbour KW, Berger FG, Wiehlmann L, Davenport C, Schuster-Gossler K, Stitz J, Cantz T, Eggenschwiler R
- Issue date: 2018 May 24